Quick Answer
ACADIA PHARMACEUTICALS INC reported Stockholders Equity of $1.23 billion for the year ending 2025.
- ACADIA PHARMACEUTICALS INC showed an increase of +67.5% in Stockholders Equity from 2024 to 2025.
- This data is from ACADIA PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2012: $12.71 million | Q3 2012: $17.66 million | Q1 2013: $79.66 million | Q2 2013: $181.48 million | Q3 2013: $180.75 million | Q1 2014: $365.46 million | Q2 2014: $350.11 million | Q3 2014: $330.49 million | Q1 2015: $285.09 million | Q2 2015: $255.82 million | Q3 2015: $227.35 million | Q1 2016: $445.25 million | Q2 2016: $408.82 million | Q3 2016: $578.06 million | Q1 2017: $457.52 million | Q2 2017: $415.14 million | Q3 2017: $377.33 million | Q1 2018: $304.17 million | Q2 2018: $264.72 million | Q3 2018: $223.44 million | Q1 2019: $418.36 million | Q2 2019: $388.91 million | Q3 2019: $689.29 million | Q1 2020: $638.38 million | Q2 2020: $663.01 million | Q3 2020: $654.87 million | Q1 2021: $581.61 million | Q2 2021: $564.84 million | Q3 2021: $566.96 million | Q1 2022: $444.80 million | Q2 2022: $434.85 million | Q3 2022: $425.69 million | Q1 2023: $374.26 million | Q2 2023: $395.79 million | Q3 2023: $362.17 million | Q1 2024: $464.04 million | Q2 2024: $516.70 million | Q3 2024: $577.18 million | Q1 2025: $765.24 million | Q2 2025: $822.38 million | Q3 2025: $917.27 million.
- Over the full 14 years of available data (2012 to 2025), ACADIA PHARMACEUTICALS INC's Stockholders Equity has grown by 1,344.3%.
- Historical annual values: Fiscal year 2025: $1.23 billion | Fiscal year 2024: $732.79 million | Fiscal year 2023: $431.76 million | Fiscal year 2022: $400.41 million | Fiscal year 2021: $540.89 million | Fiscal year 2020: $627.01 million | Fiscal year 2019: $699.14 million | Fiscal year 2018: $479.08 million | Fiscal year 2017: $335.29 million | Fiscal year 2016: $518.41 million | Fiscal year 2015: $199.76 million | Fiscal year 2014: $309.49 million | Fiscal year 2013: $182.13 million | Fiscal year 2012: $84.98 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: